Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose N-acetylcysteine in COPD: crossover pilot trial
2008-006837-28Phase 4Completed
- Sponsor
- Antwerp University Hospital
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetylcysteine in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Antwerp University Hospital. Primary endpoints: Effect of high-dose N-acetylcysteine on small airways, Effect of high-dose N-acetylcysteine on inflammation and 2 more. Started Nov 2008; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-006837-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006837-28.